Remicade Attorneys
On October 8, 2004, Johnson & Johnson warned doctors that Remicade,
may cause an increased risk of lymphoma. Despite this information from
the studies, they decided to leave the drug on the market.
It is now May 17, 2006, and doctors from the Mayo Clinic published a study
in the Journal of the American Medical Association regarding the harmful
effects of Remicade. The study confirmed earlier these studies that patients
taking Remicade could face a three-fold increase in the rate of lymphoma,
a rare blood cancer.
In the study, the doctors analyzed nine randomized, placebo-controlled
trials of Remicade and Humira, another TNF-based treatment. The trials
involved close to 3,500 patients receiving either Remicade or Humira treatment
and more than 1,500 controls receiving a placebo treatment.
Overall, patients taking either Remicade or Humira treatments had a 3.3
times higher risk of developing cancer than patients taking the placebo.
Malignancies were significantly more common in people receiving higher
doses, compared with patients receiving lower doses of Remicade or Humira.
An Attorney For You is a free consumer service. We
are not a law firm. We help consumers find the best representation for
their legal needs. Our service allows the consumer to review responses
by many law firms. This process introduces competition amongst the law
firms and allows the consumer to find superior legal representation.
Fill out one simple form and get responses from Remicade
attorneys competing for your case. Email up to 10 law
firms in one click; you review the responses in order to choose the right
attorney for you.
|
